{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:47:16Z","timestamp":1740174436348,"version":"3.37.3"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL165704","R01HL136389","R01HL131517","R01HL160992","R01HL163277","R01HL08959"],"award-info":[{"award-number":["R01HL165704","R01HL136389","R01HL131517","R01HL160992","R01HL163277","R01HL08959"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["965286"],"award-info":[{"award-number":["965286"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FE 1365\/4-1"],"award-info":[{"award-number":["FE 1365\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijcha.2024.101403","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T21:11:24Z","timestamp":1712437884000},"page":"101403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protease-activated receptor 2 at the intersection of thrombo-inflammation and beyond"],"prefix":"10.1016","volume":"52","author":[{"given":"Anke C.","family":"Fender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dobromir","family":"Dobrev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2024.101403_b0005","unstructured":"Nakano et al. Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation, In this issue."},{"key":"10.1016\/j.ijcha.2024.101403_b0010","article-title":"Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: a meta-analysis of 41,013 hospitalized patients","volume":"40","author":"Ogungbe","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijcha.2024.101403_b0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/mol.115.102723","article-title":"Thrombin-mediated direct activation of proteinase-activated Receptor-2: another Target for thrombin signaling","volume":"89","author":"Mihara","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijcha.2024.101403_b0020","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.freeradbiomed.2011.08.003","article-title":"Redox regulation of human protease-activated receptor-2 by activated factor X","volume":"51","author":"Jobi","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcha.2024.101403_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcha.2024.101403_b0030","article-title":"Proteins and pathways in atrial fibrillation and atrial cardiomyopathy underlying cryptogenic stroke","volume":"39","author":"Pal\u00e0","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijcha.2024.101403_b0035","article-title":"Contemporary trends and barriers to oral anticoagulation therapy in non-valvular atrial fibrillation during DOAC predominant era","volume":"46","author":"Sehrawat","year":"2023","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijcha.2024.101403_b0040","doi-asserted-by":"crossref","first-page":"1244098","DOI":"10.3389\/fphar.2023.1244098","article-title":"Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review","volume":"14","author":"Atzemian","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijcha.2024.101403_b0045","article-title":"Real-world clinical outcomes of oral anticoagulants among japanese patients with atrial fibrillation and concomitant coronary artery disease","volume":"49","author":"Chen","year":"2023","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijcha.2024.101403_b0050","article-title":"On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: association with treatment effects","volume":"40","author":"Hutto","year":"2022","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"10.1016\/j.ijcha.2024.101403_b0055","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br J. Pharmacol."},{"key":"10.1016\/j.ijcha.2024.101403_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s41232-022-00238-2","article-title":"Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries","volume":"42","author":"Reches","year":"2022","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.ijcha.2024.101403_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/JLB.3A0717-308R","article-title":"Protease activated-receptor 2 is necessary for neutrophil chemorepulsion induced by trypsin, tryptase, or dipeptidyl peptidase IV","volume":"103","author":"White","year":"2018","journal-title":"J. Leukoc Biol."},{"key":"10.1016\/j.ijcha.2024.101403_b0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1253\/circj.CJ-20-1006","article-title":"Activated factor X signaling pathway via protease-activated receptor 2 is a novel therapeutic Target for preventing atrial fibrillation","volume":"85","author":"Matsuura","year":"2021","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcha.2024.101403_b0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2013.09.006","article-title":"Coagulation factor xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue","volume":"718","author":"Bukowska","year":"2013","journal-title":"Eur. J. Pharmacol."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906724000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T07:22:50Z","timestamp":1716621770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906724000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":15,"alternative-id":["S2352906724000691"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101403","relation":{},"ISSN":["2352-9067"],"issn-type":[{"type":"print","value":"2352-9067"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protease-activated receptor 2 at the intersection of thrombo-inflammation and beyond","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2024.101387","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101403"}}